CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $400,716
- in 1 filing, $401K under 10b5-1 plans
Net −$400,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Sale 10b5-1 | −14,058 | $22.77 | $320K | 185,083 |
| 2026-09-08 | Cohlhepp Ryan President, COO & Interim CEO | Sale 10b5-1 | −3,442 | $23.43 | $81K | 181,641 |
| 2026-08-10 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −12,500 | $27.97 | $350K | 129,855 |
| 2026-08-10 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −10,000 | $27.98 | $280K | 362,152 |
| 2026-08-10 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −18,750 | $27.98 | $525K | 181,641 |
| 2026-07-10 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −9,972 | $28.42 | $283K | 362,180 |
| 2026-07-10 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −28 | $29.68 | $831 | 362,152 |
| 2026-07-09 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −536 | $29.00 | $16K | 181,641 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −22,833 | $28.76 | $657K | 187,558 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,306 | $29.80 | $128K | 183,252 |
| 2026-07-08 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −1,075 | $30.35 | $33K | 182,177 |
| 2026-07-08 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −22,757 | $28.60 | $651K | 135,098 |
| 2026-07-08 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −4,413 | $29.82 | $132K | 130,685 |
| 2026-07-08 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −830 | $30.31 | $25K | 129,855 |
| 2026-05-21 | Hyep Ivan Chief Financial Officer | Sale 10b5-1 | −9,200 | $20.42 | $188K | 145,355 |
| 2026-05-18 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −12,022 | $19.96 | $240K | 365,130 |
| 2026-05-18 | Mazumdar Claire Chief Executive Officer | Sale 10b5-1 | −2,978 | $20.35 | $61K | 362,152 |
| 2026-05-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −8,000 | $20.29 | $162K | 196,141 |
| 2026-05-15 | Cohlhepp Ryan President and COO | Sale 10b5-1 | −4,500 | $20.29 | $91K | 191,641 |
| 2026-04-27 | Raben David Chief Medical Officer | Sale 10b5-1 | −5,500 | $22.88 | $126K | 55,286 |
Page 1 of 4 · 76 trades